10426results about How to "Improve tolerance" patented technology

The present invention provides methods and compositions for improving plant health. In particular, application of dicamba or another substrate of DMO, or metabolites thereof including DCSA, to a plant confers tolerance to, or defense against, abiotic or biotic stresses such as oxidative stress including herbicide application, and plant disease, and enhances crop yield. Such application may be in combination with the application of another herbicide such as glyphosate.

Described herein are improved capabilities for a source resonator having a Q-factor Q1>100 and a characteristic size x1 coupled to an energy source, and a second resonator having a Q-factor Q2>100 and a characteristic size x2 coupled to an energy drain located a distance D from the source resonator, where the source resonator and the second resonator are coupled to exchange energy wirelessly among the source resonator and the second resonator.

A system and method is provided for the inductive transfer of electric power between a substantially flat primary surface and a multitude of secondary devices in such a way that the power transfer is localized to the vicinities of individual device coils. The contact free power transfer does not require precise physical alignment between the primary surface and the secondary device and can allow the secondary device or devices to be placed anywhere and in arbitrary orientation with respect to the primary surface. Such power transfer is realized without the need of complex high frequency power switching network to turn the individual primary coils on or off and is completely scalable to almost arbitrary size. The local anti-resonance architecture of the primary device will block primary current from flowing when no secondary device or devices are in proximity to the local RF power network. The presence of a tuned secondary device detunes the local anti-resonance on the primary surface; thereby enable the RF power to be transferred from the local primary coils to the secondary device. The uniformity of the inductive coupling between the active primary surface and the secondary devices is improved with a novel multi-pole driving technique which produces an apparent traveling wave pattern across the primary surface.

The disclosure provides methods and apparatus of particular benefit for patients suffering heart failure including cardiac dysfunction, chronic HF, and the like and all variants thereof. According to the disclosure monitoring and therapy delivery for a wide variety of acute and chronic cardiac dysfunctions are described and depicted. Various forms of paired or coupled pacing therapy delivery provided alone or in combination with neurostimulation therapy delivered by both implantable and external apparatus, including defibrillation therapy are also provided herein.

The present invention provides novel, serum-stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and / or administering the lipid particles. More particularly, the present invention provides serum-stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (e.g., one or more interfering RNA molecules), methods of making the SNALP, and methods of delivering and / or administering the SNALP (e.g., for the treatment of cancer). In particular embodiments, the present invention provides tumor-directed lipid particles that preferentially target solid tumors. The tumor-directed formulations of the present invention are capable of preferentially delivering a payload such as a nucleic acid to cells of solid tumors compared to non-cancerous cells.

The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen-recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired.